The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Friedman Charlene A since 2010.
The trader's CIK number is 1413748.
At the time of the last reporting, Friedman Charlene A was the VP President, Gen Counsel &Sec of Map Pharmaceuticals, Inc.. (stock ticker symbol MAPP).
Also see all insider trading activities at Map Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2013 | MAPP | 0 | $0 | 0 | $0 | 5,000 | $0 |
| 2012 | MAPP | 0 | $0 | 10,000 | $175,000 | 12,250 | $123,720 |
| 2010 | MAPP | 0 | $0 | 24,195 | $404,193 | 24,195 | $250,901 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2013-01-25 | MAPP | Option Ex | 2,750 | .00 | 0 |
| 2013-01-26 | MAPP | Option Ex | 2,250 | .00 | 0 |
| 2012-03-09 | MAPP | Option Ex | 10,000 | 12.37 | 123,720 |
| 2012-03-09 | MAPP | Sale | 10,000 | 17.50 | 175,000 |
| 2012-01-26 | MAPP | Option Ex | 2,250 | .00 | 0 |
| 2010-12-20 | MAPP | Option Ex | 3,120 | 10.37 | 32,354 |
| 2010-12-20 | MAPP | Sale | 3,120 | 15.50 | 48,360 |
| 2010-10-27 | MAPP | Option Ex | 7,800 | 10.37 | 80,886 |
| 2010-10-27 | MAPP | Sale | 7,800 | 15.53 | 121,095 |
| 2010-05-13 | MAPP | Sale | 1,560 | 17.07 | 26,633 |
| 2010-05-13 | MAPP | Option Ex | 1,560 | 10.37 | 16,177 |
| 2010-04-26 | MAPP | Option Ex | 10,155 | 10.37 | 105,307 |
| 2010-04-26 | MAPP | Sale | 10,155 | 18.03 | 183,064 |
| 2010-04-14 | MAPP | Option Ex | 1,560 | 10.37 | 16,177 |
| 2010-04-14 | MAPP | Sale | 1,560 | 16.05 | 25,041 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Friedman Charlene A (VP President, Gen Counsel &Sec of Map Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.